Evidence map›Paper›PMID 41155080›Full record

ArticleBioengineering (Basel, Switzerland)2025

Modelling of

Fabian Schröder-Kleeberg, Markus Zoellkau, Markus Glaser, Christian Bosch, Markus Brunner, Mariano Nicolas Cruz Bournazou, Peter Neubauer

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fabian Schröder-KleebergDepartment of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 76, 13355 Berlin, Germany.ORCID 0009-0006-0358-2984
Markus ZoellkauWacker Biotech GmbH, 07745 Jena, Germany.
Markus GlaserWacker Biotech GmbH, 07745 Jena, Germany.
Christian BoschWacker Chemie AG, 81379 München, Germany.ORCID 0009-0005-3105-2799
Markus BrunnerWacker Chemie AG, 81379 München, Germany.
Mariano Nicolas Cruz BournazouDepartment of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 76, 13355 Berlin, Germany.ORCID 0000-0001-9461-4414
Peter NeubauerDepartment of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 76, 13355 Berlin, Germany.ORCID 0000-0002-1214-9713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Model-based approaches provide increasingly advanced opportunities for optimizing and accelerating bioprocess development. However, to accurately capture the complexity of biotechnological processes, continuous refinement of suitable models remains essential. A crucial gap in this field has been the lack of suitable model for describing

Indexed as

complex additivesEscherichia colifed-batchmacro-kinetic modelmechanistic modelmodel-based bioprocess developmentsemi-defined mediayeast extract

Identifiers

PMID41155080
PMCPMC12561460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.